Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

Organon

Status and phase: Completed; Phase 4

Conditions: Hypertension

Treatments: Drug: MK0954, losartan potassium/Duration of Treatment: 18 weeks; Drug: Comparator: losartan, HCTZ, amlodipine, atenolol/Duration of Treatment: 18 weeks

Study type: Interventional

Funder types: Industry

Identifiers

NCT00140959

2005_061

0954A-309

Details and patient eligibility

About

A study to evaluate the effects of combination losartan versus combination atenolol in patients with ambulatory systolic hypertension.

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Males or females at least 18 years of age who have ambulatory systolic hypertension.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)